12.03.2019 • NewsDowDuPontElaine Burridgematerials science

DowDuPont Approves Materials Science Split

DowDuPont Approves Material Science Split (c) Dow
DowDuPont Approves Material Science Split (c) Dow

DowDuPont’s board of directors has approved the separation of its Materials Science division, which will become the new Dow on Apr. 1.

Shareolders in DowDuPont will receive one share of Dow common stock for every three shares of DowDuPont common stock owned on Apr. 1, the distribution date.

Dow will become an independent, publicly traded company listed on the New York Stock Exchange on or about Mar. 20. The company said it planned to buy back $3 billion of stock after the split.

Edward Breen, DowDuPont’s CEO, called the approval a major milestone toward successfully separating the businesses going to Dow. This will be followed by splitting the agriculture division, Corteva Agriscience, from the new DuPont on Jun. 1.

Breen commented: “We believe that each of the intended three independent companies is set to be an industry leader with the right management and capital structure to better serve customers, compete in their end markets and focus on their innovation priorities.”

Jim Fitterling, Dow’s CEO-elect and chief operating officer of the Materials Science division, added that the new Dow is a “more focused, disciplined and market-oriented” company.

In separate news, DowDuPont has appointed two more board members for Corteva Agriscience, taking the total to 11. The new directors are former Evonik CEO Klaus Engel and Rebecca Liebert, who recently became senior vice president for automotive coatings at PPG after more than a decade in leadership roles at Honeywell International.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.